| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8968780 | Journal of Feline Medicine & Surgery | 2005 | 7 Pages |
Abstract
Vaccine trials were undertaken to determine whether the Fel-O-Vax® FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
Ruiyu PhD, BVSc, James Coleman, James DVM, Eiji PhD, Taishi PhD, DVM, Maki DVM, Janet K PhD,